References
Aliev G, Priyadarshini M, P Reddy V, Grieg NH, Kaminsky Y, Cacabelos R et al (2014) Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease. Curr Med Chem 21(19):2208–2217
Anastasio TJ (2014) Computational identification of potential multitarget treatments for ameliorating the adverse effects of amyloid-β on synaptic plasticity. Front Pharmacol 5(85)
Anwar H (2016) Capturing intracellular Ca2+ dynamics in computational models of neurodegenerative diseases. Drug Discov Today Dis Model 19:37–42
Area-Gomez E, Schon EA (2016) Mitochondria-associated ER membranes and Alzheimer disease. Curr Opin Genet Dev 38:90–96
Area-Gomez E, Groof A, Bonilla E, Montesinos J, Tanji K, Boldogh I et al (2018) A key role for MAM is mediating mitochondrial dysfunction in Alzheimer disease. Cell Death Dis 9(3):335
Bernard-Marissal N, Moumen A, Sunyach C, Pellegrino C, Dudley K, Henderson CE et al (2012) Reduced calreticulin levels link endoplasmic reticulum stress and Fas-triggered cell death in motoneurons vulnerable to ALS. J Neurosci 32(14):4901–4912
Bernard-Marissal N, Chrast R, Schneider BL (2018) Endoplasmic reticulum and mitochondria in diseases of motor and sensory neurons: a broken relationship? Cell Death Dis 9(333):1–16
Betzer C, Lassen LB, Olsen A, Kofoed RH, Reimer L, Gregersen E et al (2018) Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. EMBO Rep 19(5):e44617
Bezprozvanny I (2013) Presenilins and calcium signaling-systems biology to the rescue. Sci Signal 6(283):pe24
Bruno AM, Huang JY, Bennett DA, Marr RA, Hastings ML, Stutzmann GE (2012) Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging 33(5):1001.e1–1001.e6
Cali T, Ottolini D, Negro A, Brini M (2012) Synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions. J Biol Chem 287(22):17914–17929
Cozzolino M, Carrì MT (2012) Mitochondrial dysfunction in ALS. Prog Neurobiol 97(2):54–66
Csordás G, Renken C, Várnai P, Walter L, Weaver D, Buttle KF et al (2006) Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol 174(7):915–921
Davey GP, Bolaños JP (2013) Peroxiredoxin 5 links mitochondrial redox signalling with calcium dynamics: impact on Parkinson’s disease. J Neurochem 125(3):332–333
De Caluwé J, Dupont G (2013) The progression towards Alzheimer’s disease described as a bistable switch arising from the positive loop between amyloids and Ca2+. J Theor Biol 331:12–18
DeKosky ST, Scheff SW (1990) Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann Neurol 27(5):457–464
Dolgacheva LP, Fedotova EI, Abramov AY, Berezhnov AV (2018) Alpha-synuclein and mitochondrial dysfunction in Parkinson’s disease. Biochem (Mosc) Suppl Ser A Membr Cell Biol 12(1):10–19
Eikelenboom P, van Exel E, Hoozemans JJM, Veerhuis R, Rozemuller AJM, van Gool WA (2010) Neuroinflammation – an early event in both the history and pathogenesis of Alzheimer’s disease. Neurodegener Dis 7(1–3):38–41
Gibson GE (2017) Interactions of mitochondria/metabolism and calcium regulation in Alzheimer’s disease: a calcinist point of view. Neurochem Res 42(6):1636–1648
Good TA, Murphy RM (1996) Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron. Proc Natl Acad Sci U S A 93(26):15130–15135
Grosskreutz J, Van Den Bosch L, Keller BU (2010) Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 47(2):165–174
Guardia-Laguarta C, Area-Gomez E, Rüb C, Liu Y, Magrané J, Becker D et al (2014) α-Synuclein is localized to mitochondria-associated ER membranes. J Neurosci 34(1):249–259
Guerrero-Hernández A, Ávila G, Rueda A (2014) Ryanodine receptors as leak channels. Eur J Pharmacol 739:26–38
Hedskog L, Pinho CM, Filadi R, Rönnbäck A, Hertwig L, Wiehager B et al (2013) Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer’s disease and related models. Proc Natl Acad Sci 110(19):7916–7921
Kelliher M, Fastbom J, Cowburn RF, Bonkale W, Ohm TG, Ravid R et al (1999) Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer’s disease neurofibrillary and beta-amyloid pathologies. Neuroscience 92(2):499–513
Kiskinis E, Sandoe J, Williams LA, Boulting GL, Moccia R, Wainger BJ et al (2014) Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell 14(6):781–795
Koffie RM, Hyman BT, Spires-Jones TL (2011) Alzheimer’s disease: synapses gone cold. Mol Neurodegener 6(1):63
Le Masson G, Przedborski S, Abbott LF (2014) A computational model of motor neuron degeneration. Neuron 83(4):975–988
Lieberman OJ, Choi SJ, Kanter E, Saverchenko A, Frier MD, Fiore GM et al (2017) α-Synuclein-dependent calcium entry underlies differential sensitivity of cultured SN and VTA dopaminergic neurons to a parkinsonian neurotoxin. eNeuro 4(6):e0167–17.2017
Ludtmann MHR, Abramov AY (2018) Mitochondrial calcium imbalance in Parkinson’s disease. Neurosci Lett 663:86–90
Mackay JP, Nassrallah WB, Raymond LA (2018) Cause or compensation?-Altered neuronal Ca2+ handling in Huntington’s disease. CNS Neurosci Ther 24(4):301–310
Manfredi G, Kawamata H (2016) Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis. Neurobiol Dis 90:35–42
Marhl M, Haberichter T, Brumen M, Heinrich R (2000) Complex calcium oscillations and the role of mitochondria and cytosolic proteins. Bio Systems 57(2):75–86
Matsuzawa T, Zalányi L, Kiss T, Érdi P (2017) Multi-scale modeling of altered synaptic plasticity related to amyloid β effects. Neural Netw 93:230–239
Morse TM, Carnevale NT, Mutalik PG, Migliore M, Shepherd GM (2010) Abnormal excitability of oblique dendrites implicated in early Alzheimer’s: a computational study. Frontiers in Neural Circuits 4(16)
Naia L, Ferreira IL, Ferreiro E, Rego AC (2017) Biochemical and biophysical research communications. Biochem Biophys Res Commun 483(4):1069–1077
Panov AV, Gutekunst C-A, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington’s disease are a direct effect of polyglutamines. Nat Neurosci 5(8):731–736
Popugaeva E, Pchitskaya E, Bezprozvanny I (2017) Biochemical and biophysical research communications. Biochem Biophys Res Commun 483(4):998–1004
Post MR, Lieberman OJ, Mosharov EV (2018) Can interactions between α-synuclein, dopamine and calcium explain selective neurodegeneration in Parkinson’s disease? Front Neurosci 12:182
Ranjan B, Chong KH, Zheng J (2018) Composite mathematical modeling of calcium signaling behind neuronal cell deathin Alzheimer’s disease. BMC Syst Biol 12(10):1–14
Rasola A, Bernardi P (2011) Mitochondrial permeability transition in Ca(2+)-dependent apoptosis and necrosis. Cell Calcium 50(3):222–233
Raymond LA (2016) Striatal synaptic dysfunction and altered calcium regulation in Huntington disease. Biochem Biophys Res Commun 483(4):1051–1062
Reese LC, Laezza F, Woltjer R, Taglialatela G (2011) Dysregulated phosphorylation of Ca(2+) /calmodulin-dependent protein kinase II-α in the hippocampus of subjects with mild cognitive impairment and Alzheimer’s disease. J Neurochem 119(4):791–804
Romani A, Marchetti C, Bianchi D, Leinekugel X, Poirazi P, Migliore M, Marie H (2013) Computational modeling of the effects of amyloid-beta on release probability at hippocampal synapses. Front Comput Neurosci 7(1)
Rowan MS, Neymotin SA, Lytton WW (2014) Electrostimulation to reduce synaptic scaling driven progression of Alzheimer’s disease. Front Comput Neurosci 8:39
Scheff SW, Price DA, Schmitt FA, DeKosky ST, Mufson EJ (2007) Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68(18):1501–1508
Smith, E. F., Shaw, P. J., & De Vos, K. J. (2017). The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett, 1–17 (in press)
Szopa P, Dyzma M, Kaźmierczak B (2013) Membrane associated complexes in calcium dynamics modelling. Phys Biol 10(3):035004
Good TA, Smith DO, Murphy RM (1996) Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons. Biophys J 70(1):296–304
Tang T-S, Tu H, Chan EYW, Maximov A, Wang Z, Wellington CL et al (2003) Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 39(2):227–239
Tang TS, Slow E, Lupu V, Stavrovskaya IG, Sugimori M, Llinas R et al (2005) Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington’s disease. Proc Natl Acad Sci 102(7):2602–2607
Tang T-S, Guo C, Wang H, Chen X, Bezprozvanny I (2009) Neuroprotective effects of inositol 1,4,5-trisphosphate receptor C-terminal fragment in a Huntington’s disease mouse model. J Neurosci 29(5):1257–1266
Tofaris GK (2012) Lysosome-dependent pathways as a unifying theme in Parkinson’s disease. Mov Disord 27(11):1364–1369
Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee S-F, Hao Y-H et al (2006) Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer’s disease-linked mutations. Cell 126(5):981–993
Walker AK, Soo KY, Sundaramoorthy V, Parakh S, Ma Y, Farg MA et al (2013) ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation. PLoS One 8(11):e81170
Wang Y, Shi Y, Wei H (2017) Calcium dysregulation in Alzheimer’s disease: a target for new drug development. J Alzheimer Dis Parkinsonism 7(5)
Wu J, Ryskamp DA, Liang X, Egorova P, Zakharova O, Hung G, Bezprozvanny I (2016) Enhanced store-operated calcium entry leads to striatal synaptic loss in a Huntington’s disease mouse model. J Neurosci 36(1):125–141
Zhang Y-J, Jansen-West K, Xu Y-F, Gendron TF, Bieniek KF, Lin W-L et al (2014) Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol 128(4):505–524
Acknowledgment
HA receives financial support from Princeton Neuroscience Institute. Parts of the text are adapted from Anwar (2016).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC, part of Springer Nature
About this entry
Cite this entry
Anwar, H. (2018). Calcium Dysregulation in Neurodegenerative Diseases. In: Jaeger, D., Jung, R. (eds) Encyclopedia of Computational Neuroscience. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7320-6_100666-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7320-6_100666-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7320-6
Online ISBN: 978-1-4614-7320-6
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences